Your browser is no longer supported. Please, upgrade your browser.
A Agilent Technologies, Inc. weekly Stock Chart
A [NYSE]
Agilent Technologies, Inc.
IndexS&P 500 P/E40.70 EPS (ttm)2.18 Insider Own0.50% Shs Outstand309.00M Perf Week1.63%
Market Cap27.82B Forward P/E24.86 EPS next Y3.57 Insider Trans-6.04% Shs Float307.66M Perf Month-2.00%
Income683.00M PEG4.35 EPS next Q0.66 Inst Own89.80% Short Float1.43% Perf Quarter22.67%
Sales5.24B P/S5.31 EPS this Y26.10% Inst Trans1.13% Short Ratio2.16 Perf Half Y3.18%
Book/sh15.43 P/B5.75 EPS next Y14.81% ROA7.40% Target Price91.25 Perf Year15.47%
Cash/sh4.22 P/C21.01 EPS next 5Y9.35% ROE14.30% 52W Range61.13 - 93.04 Perf YTD3.95%
Dividend0.72 P/FCF61.40 EPS past 5Y37.50% ROI15.20% 52W High-4.69% Beta1.12
Dividend %0.81% Quick Ratio1.20 Sales past 5Y5.00% Gross Margin53.70% 52W Low45.07% ATR1.91
Employees16370 Current Ratio1.60 Sales Q/Q0.00% Oper. Margin15.10% RSI (14)58.42 Volatility1.72% 2.29%
OptionableYes Debt/Eq0.52 EPS Q/Q-42.90% Profit Margin13.00% Rel Volume0.74 Prev Close88.11
ShortableYes LT Debt/Eq0.38 EarningsMay 21 AMC Payout30.50% Avg Volume2.04M Price88.68
Recom2.20 SMA200.60% SMA505.75% SMA20010.59% Volume1,507,599 Change0.65%
Feb-24-20Downgrade Needham Buy → Hold
Jan-08-20Initiated Wells Fargo Overweight $100
Jan-07-20Initiated Citigroup Neutral $85
Nov-26-19Reiterated Needham Buy $92 → $85
Nov-15-19Initiated Stifel Hold
Oct-18-19Downgrade UBS Buy → Neutral $82
Jul-16-19Downgrade BofA/Merrill Buy → Neutral $76
Jul-15-19Downgrade Barclays Overweight → Equal Weight $86 → $78
Jun-11-19Initiated Piper Jaffray Overweight $83
May-30-19Initiated Wolfe Research Peer Perform
Mar-15-19Initiated UBS Buy $92
Feb-25-19Reiterated Needham Buy $77 → $88
Feb-21-19Reiterated BofA/Merrill Buy $78 → $87
Jan-03-19Initiated Needham Buy $77
Nov-12-18Downgrade Cleveland Research Buy → Neutral
Apr-09-18Upgrade Goldman Neutral → Buy
Nov-21-17Reiterated Barclays Overweight $67 → $71
Sep-26-17Resumed Goldman Neutral $68
Jul-13-17Upgrade Wells Fargo Market Perform → Outperform
Mar-15-17Upgrade Morgan Stanley Equal-Weight → Overweight
Jul-02-20 12:34PM  
Jun-28-20 11:32AM  
Jun-20-20 11:30AM  
Jun-15-20 09:36AM  
Jun-11-20 10:05AM  
Jun-10-20 10:25AM  
Jun-04-20 01:51PM  
08:53AM  
Jun-03-20 03:23AM  
Jun-02-20 08:14AM  
08:10AM  
Jun-01-20 04:30PM  
11:50AM  
09:41AM  
08:48AM  
08:00AM  
May-29-20 08:32PM  
May-28-20 12:12PM  
06:13AM  
May-27-20 11:00AM  
May-25-20 03:50AM  
May-23-20 10:43AM  
12:35AM  
May-22-20 09:36AM  
01:00AM  
May-21-20 05:25PM  
04:24PM  
04:05PM  
May-20-20 04:05PM  
12:53PM  
May-19-20 01:00PM  
May-18-20 10:39AM  
May-16-20 09:15AM  
May-15-20 08:15PM  
03:08PM  
May-14-20 12:30PM  
May-12-20 08:00AM  
May-07-20 01:27PM  
May-06-20 03:06PM  
May-05-20 08:09AM  
May-01-20 06:06AM  
Apr-30-20 10:44AM  
Apr-23-20 08:00AM  
Apr-22-20 08:00AM  
Apr-17-20 09:50AM  
Apr-15-20 09:37AM  
Apr-14-20 07:10PM  
08:00AM  
Apr-07-20 08:51AM  
Apr-06-20 08:39PM  
Apr-01-20 06:20AM  
Mar-31-20 08:00AM  
Mar-30-20 01:00PM  
08:00AM  
Mar-27-20 12:20PM  
08:44AM  
Mar-26-20 06:00AM  
Mar-25-20 05:30PM  
10:52AM  
Mar-22-20 10:15AM  
Mar-20-20 05:50PM  
Mar-19-20 03:38PM  
11:30AM  
Mar-18-20 04:05PM  
Mar-17-20 04:15PM  
09:54AM  
Mar-16-20 08:00AM  
Mar-12-20 08:00AM  
Mar-11-20 09:25PM  
Mar-06-20 03:06PM  
Mar-03-20 03:30PM  
08:00AM  
Mar-02-20 11:00AM  
05:22AM  
Feb-28-20 03:02PM  
08:00AM  
Feb-27-20 11:33AM  
12:30AM  
Feb-21-20 10:15AM  
Feb-20-20 09:21AM  
Feb-19-20 01:19PM  
11:54AM  
07:41AM  
Feb-18-20 04:27PM  
04:05PM  
03:57PM  
11:03AM  
06:39AM  
Feb-16-20 03:00PM  
Feb-14-20 05:06PM  
08:56AM  
08:50AM  
07:30AM  
Feb-13-20 08:47AM  
Feb-12-20 11:54AM  
09:30AM  
Feb-11-20 12:30PM  
08:21AM  
Feb-10-20 11:58AM  
05:01AM  
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid and gas chromatography systems and components; liquid and gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate readers; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients. The Agilent CrossLab segment offers GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, and software as a service, as well as asset management and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. The company was founded in 1999 and is headquartered in Santa Clara, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FIELDS HEIDIDirectorJun 04Sale91.0010,392945,6620Jun 08 02:08 PM
Gonsalves RodneyV.P., Corporate ControllerMay 27Option Exercise40.803,100126,48046,709May 28 07:04 PM
Gonsalves RodneyV.P., Corporate ControllerMay 27Sale85.304,566389,49942,143May 28 07:04 PM
Grau DominiqueSenior Vice PresidentMay 26Option Exercise26.199,033236,574106,702May 28 07:02 PM
Thaysen JacobSr. Vice PresidentMay 26Sale86.538,000692,240102,806May 28 07:03 PM
Grau DominiqueSenior Vice PresidentMay 26Sale86.569,033781,89697,669May 28 07:02 PM
McMullen Michael R.CEO and PresidentMay 15Sale82.506,917570,653504,642May 19 03:36 PM
McMullen Michael R.CEO and PresidentMay 08Sale80.0018,0181,441,440511,559May 11 01:42 PM
McMullen Michael R.CEO and PresidentApr 29Sale78.7213,6031,070,774529,245Apr 30 02:55 PM
McMullen Michael R.CEO and PresidentApr 27Sale76.208,814671,583542,848Apr 28 04:58 PM
Doak MarkSr. Vice PresidentMar 03Sale83.813,494292,832135,678Mar 04 02:09 PM
Doak MarkSr. Vice PresidentMar 02Sale82.002,867235,094139,172Mar 03 01:48 PM
Gonsalves RodneyV.P., Corporate ControllerFeb 25Sale80.021,00080,02443,421Feb 27 01:58 PM
Grau DominiqueSenior Vice PresidentJan 17Option Exercise26.199,033236,574106,530Jan 22 11:27 AM
Grau DominiqueSenior Vice PresidentJan 17Sale90.009,033812,97097,497Jan 22 11:27 AM
Tang MichaelSVP, General Counsel, and Sec.Jan 10Sale87.725,000438,60067,167Jan 14 12:03 PM
Tang MichaelSVP, General Counsel, and Sec.Dec 30Sale85.345,000426,70072,167Jan 02 02:40 PM
Tang MichaelSVP, General Counsel, and Sec.Dec 20Option Exercise40.803,364137,25180,531Dec 20 04:38 PM
Tang MichaelSVP, General Counsel, and Sec.Dec 20Sale85.003,364285,94077,167Dec 20 04:38 PM
Grau DominiqueSenior Vice PresidentDec 12Option Exercise27.197,712209,689105,209Dec 13 07:06 PM
Doak MarkSr. Vice PresidentDec 12Sale84.508,016677,386142,017Dec 13 07:05 PM
Grau DominiqueSenior Vice PresidentDec 12Sale84.007,712647,80897,497Dec 13 07:06 PM
Grau DominiqueSenior Vice PresidentDec 11Sale82.8515,0001,242,69097,498Dec 12 08:37 PM
McMullen Michael R.CEO and PresidentDec 10Option Exercise26.1924,636645,217576,298Dec 13 07:08 PM
Tang MichaelSVP, General Counsel, and Sec.Dec 10Option Exercise40.803,364137,25180,532Dec 12 08:36 PM
Tang MichaelSVP, General Counsel, and Sec.Dec 10Sale82.903,364278,87677,168Dec 12 08:36 PM
McMullen Michael R.CEO and PresidentDec 10Sale82.9024,6362,042,324551,662Dec 13 07:08 PM
McMullen Michael R.CEO and PresidentNov 25Option Exercise26.1924,636645,217576,299Dec 13 07:08 PM
McMullen Michael R.CEO and PresidentNov 25Sale80.0024,6361,970,880551,663Dec 13 07:08 PM
Doak MarkSr. Vice PresidentNov 15Option Exercise21.53612995,912Nov 19 08:04 PM
FIELDS HEIDIDirectorSep 20Sale78.564,000314,2567,311Sep 24 04:44 PM
McMullen Michael R.CEO and PresidentSep 12Option Exercise26.1924,635645,191463,949Sep 16 05:02 PM
McMullen Michael R.CEO and PresidentSep 12Sale77.5024,6351,909,213439,314Sep 16 05:02 PM
FIELDS HEIDIDirectorAug 30Sale70.964,000283,85611,311Sep 04 06:06 PM